International Journal of Diabetes and Endocrinology

Volume 7, Issue 4, December 2022

  • Evaluation of Serum Ferritin in Type 2 Diabetes Mellitus: An Observational Study from North Sulawesi, Indonesia

    Diana Shintawati Purwanto, Yanti Meilen Mewo, Stefana Helena Margaretha Kaligis, Edmond Leonard Jim

    Issue: Volume 7, Issue 4, December 2022
    Pages: 103-108
    Received: Sep. 22, 2022
    Accepted: Oct. 10, 2022
    Published: Oct. 18, 2022
    DOI: 10.11648/j.ijde.20220704.11
    Abstract: Diabetes mellitus is still an important health problem in Indonesia because the incidence is increasing every year and most patients do not achieve good and proper glycemic control. Analysis of blood ferritin levels in type 2 diabetes mellitus patients is considered limited in many areas. As a marker of iron stores in the body, elevated serum ferri... Show More
  • Role of Resistance Training (RT) in Type 2 Diabetes Mellitus with Normal Body Mass (BMI): A Report of 3 Cases

    Vaidehi Revandkar, Bipin Gond, Rahul Mandole, Gurudatt Amin, Pravin Ghadigaonkar, Ranjeeta Kewat

    Issue: Volume 7, Issue 4, December 2022
    Pages: 109-121
    Received: Aug. 01, 2022
    Accepted: Aug. 23, 2022
    Published: Nov. 10, 2022
    DOI: 10.11648/j.ijde.20220704.12
    Abstract: Background: DM is often treated with a range of anti-diabetic medications (ADD), which can be used alone or in combination with other medicines from various classes. However, there are several side effects related with the use of these ADDs, including dizziness, fainting, gastrointestinal distress, dyspepsia, diabetic ketoacidosis, and so on. Diabe... Show More
  • A Jordanian Multidisciplinary Consensus Statement on the Management of Type 2 Diabetes

    Munther Al-Momani, Muneer Ali Abu Alsamen, Eyas Al Mousa, Mohammad Ghnaimat, Fares Haddad, Mahmoud Hashim, Mohammad Jabary, Abdelkarim Khawaldeh, Taroub Khoury, Nadima Shegem, Mazen Matalka

    Issue: Volume 7, Issue 4, December 2022
    Pages: 122-136
    Received: Nov. 03, 2022
    Accepted: Nov. 17, 2022
    Published: Nov. 23, 2022
    DOI: 10.11648/j.ijde.20220704.13
    Abstract: Background: The prevalence of type 2 diabetes (T2D) is increasing in Jordan and cardiovascular disease (CVD) is considered the leading cause of morbidity and mortality among patients with T2D patients. New data emerged with novel antihyperglycemic agents that demonstrated reduction in cardiorenal outcomes. Aims: The aims of the expert panel were to... Show More